Are you aware of any original research paper published in 2019 that led you to change your clinical practice in any way?
2020 is the third year that Simple and Practical Medical Education will be giving the annual Minerva Award for the best (published) paper that has some immediate practical utility for helping mental health patients. That is, after reading the paper, clinicians should change their clinical practice in some way. This is consistent with the mission of Simple and Practical Medical Education. You would think that the great majority of published papers would have clinical utility, but, sadly, this is not the case.
The award is called the Minerva award. As the Roman goddess of wisdom, strategic warfare, crafts, etc., she represents knowledge that is of practical use. Again, consistent with the mission of Simple and Practical Medical Education. Also, what makes the name even more appropriate is that Minerva was also the goddess of medicine and physicians (and, therefore, called Minerva Medica).
The awardee receives a plaque from Simple and Practical Medical Education and a check for $1000. In addition to the winner, we will announce a list of other papers that the judges have commended for being of practical use.
We invite nominations from anyone who cares to submit them. Nominations for the best paper with immediate practical utility for helping mental health patients should be posted at the bottom of this page or emailed to mago@simpleandpractical.com by the deadline that will be announced each year. For 2020, the deadline is midnight on Friday, February 21, 2020.
Judges
The papers will be judged by a distinguished panel consisting of the members of the Editorial Board of Simple and Practical Medical Education who are (alphabetically): Chittaranjan Andrade MD, Vivien Burt MD, Anita Clayton MD, Leslie Citrome MD, Jose De Leon MD, Heinz Grunze MD, Joseph Goldberg MD, Rajnish Mago MD, Henry Nasrallah MD, Katharine Phillips MD, Gary Sachs MD, Michael Thase MD, and Mark Zimmerman MD.
Rules
– Any original research paper is eligible, including a meta-analysis. Review articles are not eligible. The paper must have been published between January 1 and December 31 of the year for which the award is being given. The e-publishing date is not considered.
– Studies conducted by pharmaceutical companies are not eligible for this award even though they are often of great practical use, but investigator-initiated studies are not excluded.
– The award is NOT limited to early career psychiatrists.
– Authors may nominate their own papers if they wish
– If one of the judges is a co-author on a paper that is nominated, that person will not vote with regard to that paper
– Judging of the papers will be done anonymously
– The decision of the judges will be final in all matters related to this award.
Results and celebration
– The paper that won the award and papers that were commended by the judges will be announced on or around March 15 of each year.
– As noted above, the awardee will receive a plaque from Simple and Practical Medical Education and a check for $1000.
– It will be up to the corresponding author to decide whether and how the award should be shared with any co-authors.
– The authors of the winning paper and of papers that are commended will be invited to a celebration to be held at the same time as the annual meeting of the American Psychiatric Association though the award is NOT affiliated with the APA in any way.
Related Pages
Minerva award winners and commended papers 2019
Minerva award winners and commended papers 2018
Copyright © 2017 to 2020, Simple and Practical Medical Education, LLC, and Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.
Patel RS, Jain SB, Youssef NA. Electroconvulsive Treatment Utilization for the Inpatient Management of Severe Manic Episodes of Bipolar Disorder. J ECT. 2019;35(3):195–200. doi:10.1097/YCT.0000000000000587
Patients treated with ECT are generally sicker and more treatment resistant. However, ECT should not be considered only as a “last resort” in the treatment algorithm. Inpatient ECT for patients with MEs if initiated during the first 7 days of hospitalization reduces length of stay and cost.
Patel RS, Patel J, Jaladi PR, Bhimanadham NN, Imran S, Tankersley WE. Burden of Persistent Vomiting With Cannabis Use Disorder: Report From 55,549 Hospitalizations in the United States. Psychosomatics. 2019;60(6):549–555. doi:10.1016/j.psym.2019.07.003
This study found that cannabis use was independently associated with a 609% increased likelihood of PV-related hospitalization, and this association persisted even after adjusting for known risk factors and other substances.
Can we nominate a paper that is accepted for publication? I can send the full text to Dr. Mago for evaluation.
Also, one of my other studies is published online ahead of print, so is it eligible for this contest>? Please let me know about this. Thanks.
Rikin Patel
Thanks. To be eligible, the paper must be in print (not just online) in the calendar year being considered. Please nominate them once they are published. Good luck!
In many countries patients with first episode schizophrenia spectrum disorder are still being treated by haloperidol for various reasons including habitual practice based on routine, notion ( without evidence) that haloperidol is “superior in reducing hallucinations and calming down aggressive patient” etc. However in recent network meta-analysis research group of professor Stefan Leucht has demonstrated that haloperidol may be suboptimal treatment for the first episode psychosis, mainly because of somewhat inferior efficacy compared to olanzapine, amisulpride or risperidone. Prior to pairwise and network meta-analysis Professor Leucht’s group conducted meticulous and thorough search and careful review of conducted randomized studies in first episode psychosis adhering to strict and high methodological standards of Cochrane group.
Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses.
Zhu Y, Krause M, Huhn M, Rothe P, Schneider-Thoma J, Chaimani A, Li C, Davis JM, Leucht S.Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses.Lancet Psychiatry. 2017, 4(9):694-705